Healthcare >> CEO Interviews >> June 18, 2001

Dr. Philip Reilly – Interleukin Genetics (ilgn)

DR. PHILIP R. REILLY is CEO of Interleukin Genetics, Inc., in Waltham, Massachusetts. From 1990 to 2000 he was the Executive Director of the Shriver Center for Mental Retardation, Inc. Dr. Reilly has held faculty appointments at Harvard Medical School and Brandeis University. He is currently an Assistant Professor at Tufts University School of Medicine. He is also President of the American Society of Law, Medicine, and Ethics, a not-for-profit organization headquartered in Boston. He has served on many national committees chartered to explore public policy issues raised by advances in genetics and is frequently asked to comment on these topics by the national media. He is the author of three books and has published more than 100 articles in scholarly journals. Profile
TWST: Could we begin with a brief historical sketch of the company and

then an overview?

Dr. Reilly: Interleukin Genetics is a company that was created under

another name, Medical Science